Skip to main content
Premium Trial:

Request an Annual Quote

BGI Genomics Nabs CE Mark for Colorectal Cancer Screening Test

NEW YORK – BGI Genomics announced on Wednesday that its colorectal cancer screening test has received CE marking.

The DNA Methylation Detection Kit for Human SDC2, ADHFE1, and PPP2R5C Genes can detect abnormal methylation of the genes in stool DNA from human fecal samples. The genes are highly specific markers for colorectal cancer cells, the company said in a statement.

The noninvasive test is intended to help diagnose patients who are recommended by clinicians to receive a diagnostic colonoscopy.

Shenzhen, China-based BGI Genomics is the clinical genetic testing and research services arm of China's BGI Group.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.